MARSHALL WACE, LLP - GENMAB A/S ownership

GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 232 filers reported holding GENMAB A/S in Q4 2022. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of GENMAB A/S
ValueSharesWeighting
Q3 2023$7,434,881
+2024.1%
210,799
+2452.4%
0.02%
+1400.0%
Q4 2022$350,017
+24.1%
8,259
-3.9%
0.00%0.0%
Q1 2021$282,000
-89.5%
8,595
-87.0%
0.00%
-93.3%
Q4 2020$2,685,000
-67.4%
66,042
-70.7%
0.02%
-71.7%
Q3 2020$8,238,000
-52.9%
225,029
-56.4%
0.05%
-56.9%
Q2 2020$17,498,000
+248.0%
516,303
+117.6%
0.12%
+146.0%
Q1 2020$5,028,000237,3000.05%
Other shareholders
GENMAB A/S shareholders Q4 2022
NameSharesValueWeighting ↓
Hansberger Growth Investors, LP 69,915$2,560,0002.90%
First Light Asset Management, LLC 603,870$22,108,0002.26%
Hardman Johnston Global Advisors LLC 1,052,596$38,536,0001.44%
Cutter & CO Brokerage, Inc. 125,650$4,600,0001.36%
TORRAY INVESTMENT PARTNERS LLC 151,464$5,545,0001.02%
NAVELLIER & ASSOCIATES INC 110,620$4,050,0000.88%
Faithward Advisors, LLC 97,012$3,552,0000.86%
Ativo Capital Management LLC 36,452$1,334,0000.64%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 56,804$2,080,0000.61%
Dorsey Wright & Associates 86,502$3,167,0000.57%
View complete list of GENMAB A/S shareholders